Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status
Subscribe to Our Newsletter
You are leaving the U.S. & Canada Research Use Only (RUO) area.
The content you are about to access is intended for other markets and may include products or information not available in the U.S. or Canada.